Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization-Reference-Cited by-同舟云学术

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Published:2021-07-08 Issue:7871 Volume:596 Page:276-280
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Planas Delphine,Veyer David,Baidaliuk Artem^ORCID,Staropoli Isabelle,Guivel-Benhassine Florence,Rajah Maaran Michael^ORCID,Planchais Cyril,Porrot Françoise^ORCID,Robillard Nicolas,Puech Julien,Prot Matthieu,Gallais Floriane,Gantner Pierre,Velay Aurélie,Le Guen Julien,Kassis-Chikhani Najiby,Edriss Dhiaeddine,Belec Laurent,Seve Aymeric,Courtellemont Laura,Péré Hélène,Hocqueloux Laurent^ORCID,Fafi-Kremer Samira,Prazuck Thierry,Mouquet Hugo,Bruel Timothée^ORCID,Simon-Lorière Etienne^ORCID,Rey Felix A.^ORCID,Schwartz Olivier^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-021-03777-9.pdf

Reference30 articles.

1. Yadav, P. D. et al. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciab411 (2021).

2. Ferreira, I. et al. SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies. Preprint at https://doi.org/10.1101/2021.05.08.443253 (2021).

3. Hoffmann, M. et al. SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. https://doi.org/10.1016/j.celrep.2021.109415 (2021).

4. Cherian, S. et al. Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. Preprint at https://doi.org/10.1101/2021.04.22.440932 (2021).

5. Edara, V.-V. et al. Infection and vaccine-induced neutralizing-antibody responses to the SARS-CoV-2 B.1.617 variants. New Eng. J. Med. https://doi.org/10.1056/NEJMc2107799 (2021).

Cited by 1609 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Delta and Omicron community transmission networks as added value to contact tracing;Journal of Infection;2024-02

2. Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted;eBioMedicine;2024-02

3. Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice;Applied Microbiology and Biotechnology;2024-01-27

4. SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency;Science Translational Medicine;2024-01-24

5. Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation;Journal of Virology;2024-01-23